Clinical Trials Directory

Trials / Unknown

UnknownNCT04478032

Deep Transcranial Magnetic Stimulation for the Treatment of Treatment Resistance Schizophrenia

Deep Transcranial Magnetic Stimulation for the Treatment of Treatment Resistance Schizophrenia: a Double-Blind, Randomized Clinical Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Shanghai Mental Health Center · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Based on the hypothesis that low-frequency deep transcranial magnetic stimulation(dTMS) on anterior cingulate cortex (ACC) could down-regulate the glutamate level of ACC and regulate the acc-related functional network in patients with treatment resistance schizophrenia,this research plan to utilise multimodal functional magnetic imaging method(including structural MRI,resting-state functional magnetic resonance imaging and 1H-MRS) to investigate therapeutic efficacy of low-frequency deep transcranial magnetic stimulation on SZ patients symptoms,as well as to elucidate the correlation between treatment effects and glutamate level of ACC

Detailed description

This study includes 20 treatment resistance schizophrenia patients and 20 healthy controls.This study will investigate 1)abnormalities of the glutamate level of ACC in patients with schizophrenia compared to healthy controls by using 1H-MRS technique. 2)potential modulation effects of deep transcranial magnetic stimulation(dTMS) on anterior cingulate cortex function of patients with schizophrenia. 3)the therapeutic efficacy of dTMS on cognitive impairments and other psychotic symptoms of patients with schizophrenia by adopting cognitive function and psychotic symptoms evaluation,as well as to explore the optimal dTMS treatment pattern on cognitive function.

Conditions

Interventions

TypeNameDescription
DEVICEdeep transcranial magnetic stimulation with H7 coillow frequency(1Hz) deep transcranial magnetic stimulation on ACC .Duration:20 days.

Timeline

Start date
2020-07-05
Primary completion
2022-12-01
Completion
2022-12-30
First posted
2020-07-20
Last updated
2021-09-14

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04478032. Inclusion in this directory is not an endorsement.